CN101601665A - 1r,2s-甲氧胺在制备治疗大便失禁和其他相关疾病的药物中的应用 - Google Patents

1r,2s-甲氧胺在制备治疗大便失禁和其他相关疾病的药物中的应用 Download PDF

Info

Publication number
CN101601665A
CN101601665A CNA2009101594203A CN200910159420A CN101601665A CN 101601665 A CN101601665 A CN 101601665A CN A2009101594203 A CNA2009101594203 A CN A2009101594203A CN 200910159420 A CN200910159420 A CN 200910159420A CN 101601665 A CN101601665 A CN 101601665A
Authority
CN
China
Prior art keywords
methoxamine
purposes
described medicine
dosage
peak
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2009101594203A
Other languages
English (en)
Chinese (zh)
Inventor
诺曼·巴雷斯
杰弗里·马丁·汤普森
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Norgine Europe BV
Original Assignee
Norgine Europe BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norgine Europe BV filed Critical Norgine Europe BV
Publication of CN101601665A publication Critical patent/CN101601665A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/08—Mydriatics or cycloplegics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/10—Separation; Purification; Stabilisation; Use of additives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/64—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by singly-bound oxygen atoms
    • C07C217/66—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by singly-bound oxygen atoms with singly-bound oxygen atoms and six-membered aromatic rings bound to the same carbon atom of the carbon chain
    • C07C217/70—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by singly-bound oxygen atoms with singly-bound oxygen atoms and six-membered aromatic rings bound to the same carbon atom of the carbon chain linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CNA2009101594203A 2001-12-21 2002-12-20 1r,2s-甲氧胺在制备治疗大便失禁和其他相关疾病的药物中的应用 Pending CN101601665A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0130763.6 2001-12-21
GBGB0130763.6A GB0130763D0 (en) 2001-12-21 2001-12-21 Treatment methods

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CNA028253248A Division CN1604773A (zh) 2001-12-21 2002-12-20 用1r,2s－甲氧胺治疗大便失禁和其他相关疾病

Publications (1)

Publication Number Publication Date
CN101601665A true CN101601665A (zh) 2009-12-16

Family

ID=9928258

Family Applications (3)

Application Number Title Priority Date Filing Date
CNA2009101594203A Pending CN101601665A (zh) 2001-12-21 2002-12-20 1r,2s-甲氧胺在制备治疗大便失禁和其他相关疾病的药物中的应用
CNA028253248A Pending CN1604773A (zh) 2001-12-21 2002-12-20 用1r,2s－甲氧胺治疗大便失禁和其他相关疾病
CN2011104050612A Pending CN102516101A (zh) 2001-12-21 2002-12-20 1r,2s-甲氧胺在制备治疗大便失禁和其他相关疾病的药物中的应用

Family Applications After (2)

Application Number Title Priority Date Filing Date
CNA028253248A Pending CN1604773A (zh) 2001-12-21 2002-12-20 用1r,2s－甲氧胺治疗大便失禁和其他相关疾病
CN2011104050612A Pending CN102516101A (zh) 2001-12-21 2002-12-20 1r,2s-甲氧胺在制备治疗大便失禁和其他相关疾病的药物中的应用

Country Status (12)

Country Link
US (3) US20050096397A1 (enExample)
EP (2) EP1458370A1 (enExample)
JP (3) JP5486143B2 (enExample)
CN (3) CN101601665A (enExample)
AU (1) AU2002353206B2 (enExample)
CA (1) CA2471046C (enExample)
GB (1) GB0130763D0 (enExample)
MX (1) MXPA04006142A (enExample)
PL (1) PL217404B1 (enExample)
RU (1) RU2332989C2 (enExample)
WO (1) WO2003055474A1 (enExample)
ZA (1) ZA200404813B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0130763D0 (en) * 2001-12-21 2002-02-06 Norgine Res Ltd Treatment methods
GB0501580D0 (en) * 2005-01-25 2005-03-02 Norgine Europe Bv Compounds for treating urinary incontinence
EP2473056A4 (en) 2009-09-04 2013-02-13 Glaxosmithkline Llc CHEMICAL COMPOUNDS
ES2630102T3 (es) * 2011-04-26 2017-08-18 Rdd Pharma Ltd. Oximetazolina para el tratamiento de trastornos ano-rectales
CN102976961B (zh) * 2012-12-24 2014-09-24 武汉武药制药有限公司 盐酸甲氧明的制备方法
US10708086B2 (en) * 2016-01-19 2020-07-07 National Instruments Corporation Channel sounding techniques

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1593261A (en) * 1976-07-23 1981-07-15 Inveresk Res Int Controlled release suppository
JPS60172953A (ja) * 1984-02-17 1985-09-06 Sagami Chem Res Center 光学活性β−アミノアルコ−ルの製造方法
FR2647014B1 (fr) * 1989-05-16 1991-08-30 Paris V Universite Composition medicamenteuse pour le traitement et la prevention des symptomes de l'insuffisance cardiaque, renfermant un agent alpha-stimulant vasoconstricteur comme principe actif
DK339289D0 (da) 1989-07-07 1989-07-07 Dak Lab As Farmaceutisk praeparat
DK469989D0 (da) * 1989-09-22 1989-09-22 Bukh Meditec Farmaceutisk praeparat
NL9102142A (nl) * 1991-12-20 1993-07-16 Dagra Pharma Bv Zetpillen met vertraagde afgifte en werkwijze voor de bereiding daarvan.
US6635678B1 (en) * 1996-12-23 2003-10-21 S.L.A. Pharma Ag Pharmaceutical composition for treating fecal incontinence
WO1998038587A1 (en) * 1997-02-26 1998-09-03 Siebel Systems, Inc. Method of using a cache to determine the visibility to a remote database client of a plurality of database transactions
US6539381B1 (en) * 1999-04-21 2003-03-25 Novell, Inc. System and method for synchronizing database information
GB0028575D0 (en) * 2000-11-23 2001-01-10 Elan Corp Plc Oral pharmaceutical compositions containing cyclodextrins
US6544927B2 (en) * 2001-04-28 2003-04-08 University Of Florida Use of α2-adrenergic receptor agonists and adrenergic inhibitors in reducing defoliation
GB0130763D0 (en) 2001-12-21 2002-02-06 Norgine Res Ltd Treatment methods
US7089228B2 (en) * 2002-04-18 2006-08-08 International Business Machines Corporation Computer apparatus and method for caching results of a database query

Also Published As

Publication number Publication date
WO2003055474A1 (en) 2003-07-10
US20100022657A1 (en) 2010-01-28
GB0130763D0 (en) 2002-02-06
MXPA04006142A (es) 2005-03-31
PL369828A1 (en) 2005-05-02
US20050096397A1 (en) 2005-05-05
PL217404B1 (pl) 2014-07-31
JP2005519888A (ja) 2005-07-07
CA2471046A1 (en) 2003-07-10
US8613948B2 (en) 2013-12-24
JP5544535B2 (ja) 2014-07-09
JP2012025782A (ja) 2012-02-09
ZA200404813B (en) 2005-10-26
EP2275099A1 (en) 2011-01-19
JP2011105770A (ja) 2011-06-02
AU2002353206B2 (en) 2008-09-04
RU2332989C2 (ru) 2008-09-10
CA2471046C (en) 2012-02-07
RU2004122639A (ru) 2005-05-10
CN1604773A (zh) 2005-04-06
AU2002353206A1 (en) 2003-07-15
CN102516101A (zh) 2012-06-27
EP1458370A1 (en) 2004-09-22
US20130072567A1 (en) 2013-03-21
JP5486143B2 (ja) 2014-05-07
US8491931B2 (en) 2013-07-23

Similar Documents

Publication Publication Date Title
CA2976634C (en) Fluorinated tetrahydronaphthyridinyl nonanoic acid derivatives and uses thereof
USRE40259E1 (en) Alpha-aminoamide derivatives useful as analgesic agents
DE69629670T2 (de) Lactam-enthaltende hydroxamsäure-derivate, deren herstellung und deren verwendung als inhibitoren von matrix-metalloproteasen
TW200812574A (en) Co-therapy for the treatment of epilepsy and related disorders
JP2009537565A (ja) Ｒ（＋）およびｓ（−）プラミペキソール組成とそれを利用する方法
US8613948B2 (en) Treatment of faecal incontinence and other conditions with 1R, 2S-methoxamine
AU707142B2 (en) Meta substituted arylalkylamines and therapeutic and diagnostic uses therefor
TW202345795A (zh) 純質形式之結晶型阿替卡普蘭
AU2021337583A9 (en) Compositions and methods for improving neurological diseases and disorders
KR20150020160A (ko) 과민성 방광의 치료를 위한 무스카린 수용체 길항제 및 베타―3 아드레날린 수용체 작용제의 조합물
JPS58208255A (ja) アミノアルカジエン誘導体
JP5384487B2 (ja) 新規方法
CN103826622A (zh) 用于预防或治疗情感障碍的n-取代的苯丙酰胺或苯丙烯酰胺
US20050100509A1 (en) Radiotracers for in vivo study of acetylcholinesterase and Alzheimer's disease
HK1169369A (en) Use of 1 r, 2s-methoxamine in preparing medicines for treating faecal incontinence and other conditions
CN103127520A (zh) 聚乙二醇与坦索罗辛的结合物及其药物组合物
WO2015188005A1 (en) Novel (r)-isometheptene compositions and uses
JPH03181419A (ja) イミダゾピリジンを含有する麻酔薬
WO2024061251A1 (zh) 一种4-tmap治疗或缓解抑郁症的用途
WO2021216753A1 (en) Fluorinated derivatives of gabapentin and methods of use thereof
CN110563601A (zh) 一种具有镇痛、镇静作用的化合物及其应用
JPH0376302B2 (enExample)
HK1014671B (en) Meta substituted arylalkylamines and therapeutic and diagnostic uses thereof
TW200808300A (en) Use of benzo-heteroaryl sulfamide derivatives for the treatment of disease modification/epileptogenesis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20091216